Fol. Biol. 2010, 56, 51-57

https://doi.org/10.14712/fb2010056020051

CCAAT/Enhancer-Binding Protein α (CEBPA) Polymorphisms and Mutations in Healthy Individuals and in Patients with Peripheral Artery Disease, Ischaemic Heart Disease and Hyperlipidaemia

Ota Fuchs1, A. Kostečka1, D. Provazníková1, B. Krásná1, R. Kotlín1, M. Staňková1, P. Kobylka1, G. Dostálová2, M. Zeman3, M. Chochola2

1Department of Cell Physiology, Institute of Haematology and Blood Transfusion, Prague, Czech Republic
22nd Department of Internal Medicine, Charles University in Prague, First Faculty of Medicine and General University Hospital, Prague, Czech Republic
34th Department of Internal Medicine, Charles University in Prague, First Faculty of Medicine and General University Hospital, Prague, Czech Republic

Received July 2009
Accepted August 2009

Crossref Cited-by Linking

  • Pan Lili, Li Yining, Gao Huiying, Lai Xiaolin, Cai Yuanhua, Chen Zhixiang, Li Xiaofan, Wang Shao-yuan: Clinical features and management of germline CEBPA-mutated carriers. Leukemia Research 2024, 138, 107453. <https://doi.org/10.1016/j.leukres.2024.107453>
  • Yuan Zixun, Murakoshi Nobuyuki, Xu Dongzhu, Tajiri Kazuko, Okabe Yuta, Aonuma Kazuhiro, Murakata Yoshiko, Li Siqi, Song Zonghu, Shimoda Yuzuno, Mori Haruka, Aonuma Kazutaka, Ieda Masaki: Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets. Life Sciences 2022, 306, 120807. <https://doi.org/10.1016/j.lfs.2022.120807>
  • Krawiec Kinga, Strza\u0142ka Piotr, Czemerska Magdalena, Wi\u015bnik Aneta, Zawlik Izabela, Wierzbowska Agnieszka, Pluta Agnieszka: Targeting Apoptosis in AML: Where Do We Stand?. Cancers 2022, 14, 4995. <https://doi.org/10.3390/cancers14204995>
Crossref Cited-by Linking logo